Does URAPIDIL Cause Agranulocytosis? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Agranulocytosis have been filed in association with URAPIDIL. This represents 0.8% of all adverse event reports for URAPIDIL.
13
Reports of Agranulocytosis with URAPIDIL
0.8%
of all URAPIDIL reports
0
Deaths
13
Hospitalizations
How Dangerous Is Agranulocytosis From URAPIDIL?
Of the 13 reports, 13 (100.0%) required hospitalization.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for URAPIDIL. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does URAPIDIL Cause?
Acute kidney injury (187)
Fall (150)
Hypotension (148)
Hyperkalaemia (78)
Drug ineffective (77)
Hyponatraemia (69)
Bradycardia (66)
Toxic epidermal necrolysis (63)
Condition aggravated (61)
Dizziness (60)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which URAPIDIL Alternatives Have Lower Agranulocytosis Risk?
URAPIDIL vs UREA
URAPIDIL vs URIDINE TRIACETATE
URAPIDIL vs UROFOLLITROPIN
URAPIDIL vs URSODIOL
URAPIDIL vs USTEKINUMAB